Delivery Order SPE2DB20D1100-SPE2DB24FD5Z1

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,849.85 firm fixed-price delivery order contract is for the supply of OJJAARA 200 MG TABLET UU 30S medical products. The contract has an ultimate completion date of April 23, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $17,912.32 firm fixed-price delivery order is for the supply of OJJAARA 100 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 28, 2025 and is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,849.85 firm fixed-price delivery order contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a medical product. The contract has an ultimate completion date of February 4, 2025 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $17,758.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 26, 2024 and was awarded on December 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $17,849.85 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through July 28, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,849.85 firm-fixed-price delivery order contract has a period of performance through March 26, 2025 and is not associated with a set-aside requirement. The contract provides for the delivery of OJJAARA 200 MG TABLET UU 30S, which appears to be a pharmaceutical product. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,165.69 delivery order is for the supply of OJJAARA 200 MG TABLET, with a completion date of November 27, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,849.85, is a delivery order for 4567618096 OJJAARA 200 MG TABLET UU 30S. It is a firm fixed price contract type with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,849.85, is for the delivery of OJJAARA 200 MG TABLET UU 30S to support federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $53,549.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OJJAARA 200 MG TABLET UU 30S, a medical product, with a period of performance through April 4, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD5Z1
    Delivery Order

This federal contract award, valued at $34,331.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OJJAARA 200 MG TABLET UU 30S, a prescription medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is September 24, 2024. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives. This contract award is not associated with a set-aside designation.

Generated 12/3/24, 9:42 AM